Lv1
16 积分 2022-09-19 加入
2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway
3天前
已完结
Enhanced CAR T cell therapy offers new strategy for lymphoma
1个月前
已完结
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
1个月前
已完结
Quadruple adenine base–edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease–engineered T cells
1个月前
已完结
Trends in the drug target landscape for autoimmune disease
2个月前
已完结
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial
2个月前
已完结
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial
2个月前
已完结
BCMA-CAR T-cells in a patient with relapsing idiopathic inflammatory myositis after CD19-CAR T-cells
2个月前
已完结
Engineering innate immune cells for cancer immunotherapy
2个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
3个月前
已完结
皖公网安备34019202002308
